Articles by The Wall Street Analyzer

About The Wall Street Analyzer
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
News Feed

21st Century Marketing Group Licenses Zerify Defender to Protect Confidential Client Data

December 19, 2022 The Wall Street Analyzer Comments Off on 21st Century Marketing Group Licenses Zerify Defender to Protect Confidential Client Data

EDISON, N.J., Dec. 19, 2022 (GLOBE NEWSWIRE) — Zerify Inc., (OTCQB: ZRFY), the 21-year-old cybersecurity company focused on secure video conferencing solutions, today announced that 21st Century Marketing Group has licensed Zerify Defender to protect confidential […]

News Feed

Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans

December 15, 2022 The Wall Street Analyzer Comments Off on Zomedica CEO Interview with Wall Street Analyzer Updates Company Progress and Plans

ANN ARBOR, MI / ACCESSWIRE / December 15, 2022 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announces an update interview with the […]

No Picture
CEO Interviews

Predictive Oncology (NASDAQ: POAI)

December 13, 2022 The Wall Street Analyzer Comments Off on Predictive Oncology (NASDAQ: POAI)

ABOUT: Predictive Oncology (NASDAQ: POAI) is a knowledge-driven company focused on applying artificial intelligence (AI) to develop optimal cancer therapies, which can ultimately lead to more effective treatments and improved patient outcomes. Through AI, Predictive Oncology uses […]